WallStreetZenWallStreetZen

NASDAQ: MDWD
Mediwound Ltd Stock

$14.52+1.06 (+7.88%)
Updated Jun 24, 2024
MDWD Price
$14.52
Fair Value Price
-$7.14
Market Cap
$134.08M
52 Week Low
$7.10
52 Week High
$19.86
P/E
-10.52x
P/B
5.78x
P/S
6.63x
PEG
N/A
Dividend Yield
N/A
Revenue
$19.85M
Earnings
-$12.75M
Gross Margin
16.9%
Operating Margin
-44.49%
Profit Margin
-64.2%
Debt to Equity
1.69
Operating Cash Flow
-$16M
Beta
0.68
Next Earnings
Aug 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A

MDWD Overview

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MDWD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MDWD ($14.52) is overvalued by 303.43% relative to our estimate of its Fair Value price of -$7.14 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
MDWD ($14.52) is not significantly undervalued (303.43%) relative to our estimate of its Fair Value price of -$7.14 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MDWD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MDWD due diligence checks available for Premium users.

Be the first to know about important MDWD news, forecast changes, insider trades & much more!

MDWD News

Valuation

MDWD fair value

Fair Value of MDWD stock based on Discounted Cash Flow (DCF)
Price
$14.52
Fair Value
-$7.14
Undervalued by
303.43%
MDWD ($14.52) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MDWD ($14.52) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MDWD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MDWD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-10.52x
Industry
-6.96x
Market
30.03x

MDWD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.78x
Industry
6.29x
MDWD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MDWD's financial health

Profit margin

Revenue
$5.0M
Net Income
-$9.7M
Profit Margin
-196%
MDWD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MDWD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$62.4M
Liabilities
$39.2M
Debt to equity
1.69
MDWD's short-term assets ($44.20M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MDWD's short-term assets ($44.20M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MDWD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MDWD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.6M
Investing
-$1.8M
Financing
-$699.0k
MDWD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MDWD vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
MDWD$134.08M+7.88%-10.52x5.78x
SGMT$134.04M+6.87%-0.11x0.71x
RGLS$134.21M-18.33%-1.41x1.25x
ELEV$133.86M-4.30%-2.50x1.77x
ATOS$134.56M-5.31%-4.46x1.57x

Mediwound Stock FAQ

What is Mediwound's quote symbol?

(NASDAQ: MDWD) Mediwound trades on the NASDAQ under the ticker symbol MDWD. Mediwound stock quotes can also be displayed as NASDAQ: MDWD.

If you're new to stock investing, here's how to buy Mediwound stock.

What is the 52 week high and low for Mediwound (NASDAQ: MDWD)?

(NASDAQ: MDWD) Mediwound's 52-week high was $19.86, and its 52-week low was $7.10. It is currently -26.89% from its 52-week high and 104.51% from its 52-week low.

How much is Mediwound stock worth today?

(NASDAQ: MDWD) Mediwound currently has 9,234,104 outstanding shares. With Mediwound stock trading at $14.52 per share, the total value of Mediwound stock (market capitalization) is $134.08M.

Mediwound stock was originally listed at a price of $120.89 in Mar 20, 2014. If you had invested in Mediwound stock at $120.89, your return over the last 10 years would have been -87.99%, for an annualized return of -19.1% (not including any dividends or dividend reinvestments).

How much is Mediwound's stock price per share?

(NASDAQ: MDWD) Mediwound stock price per share is $14.52 today (as of Jun 24, 2024).

What is Mediwound's Market Cap?

(NASDAQ: MDWD) Mediwound's market cap is $134.08M, as of Jun 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mediwound's market cap is calculated by multiplying MDWD's current stock price of $14.52 by MDWD's total outstanding shares of 9,234,104.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.